Skip to content
‹ Back to IndustriesSciences

World Metrology Day, 2018

May 20, 2018, is World Metrology Day. Metrology, the science of measurement, impacts our everyday lives in many ways: some are subtle, and others are quite significant. For example, metrology plays a central role in scientific discovery, as well as manufacturing and trade; it’s also critical in improving our quality of life and protecting our…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

Promoted content from Zygo Corporation on MarketScale.

By Sciences · · Promoted Content
Share
World Metrology Day, 2018

Key takeaways

01

May 20, 2018, is World Metrology Day.

02

Metrology, the science of measurement, impacts our everyday lives in many ways: some are subtle, and others are quite significant.

03

For example, metrology plays a central role in scientific discovery, as well as manufacturing and trade; it’s also critical in improving our quality of life and protecting our…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

May 20, 2018, is World Metrology Day. Metrology, the science of measurement, impacts our everyday lives in many ways: some are subtle, and others are quite significant. For example, metrology plays a central role in scientific discovery, as well as manufacturing and trade; it’s also critical in improving our quality of life and protecting our planet.

World Metrology Day celebrates the date in 1875 when representatives of seventeen nations signed The Metre Convention. The Convention set the structure for global collaboration in the science of measurement and its industrial, commercial, and societal applications. The original aim of the Metre Convention, the worldwide uniformity of measurement, remains as relevant today as it was in 1875.

The theme for World Metrology Day 2018 is Constant Evolution of the International System of Units. In November 2018, the General Conference on Weights and Measures is expected to agree on one of the most significant revisions to the International System of Units (the SI) since its beginning. These changes will incorporate new research into new measurement methods using quantum phenomena, and each set of definitions will be linked to the laws of physics. These definitions will be adaptable to anticipated improvements in measurement science. Thus, the proposed changes will have wide-ranging ramifications now and in the future.

Zygo Corporation will honor World Metrology Day 2018, as it does every year, as a global leader in the design and manufacture of advanced optical metrology systems and ultra-precise optical components and assemblies. Just as this year’s theme focuses on evolution, so does Zygo Corporation.

As it is our company’s mission to promote customer success by delivering innovative precision optical metrology solutions, developments at Zygo Corporation have far-reaching implications. ZYGO is exceedingly proud of our efforts in enabling researchers, engineers and students have a better understanding of surfaces, generated or natural.

As ZYGO continues to develop and implement novel ideas, expanding our portfolio of over 750 current US patents into our instruments, ZYGO looks to the future; expanding opportunities where non-contact areal metrology can provide understanding and awareness for all purveyors of metrology.

Read more at zygo.com

Zygo Corporation

Part of this channel

Zygo Corporation

Precision Optical Metrology & Optics Solutions

Visit the channel

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512